Literature DB >> 11291068

p53 Mutations are present in colorectal cancer with cytoplasmic p53 accumulation.

A Jansson1, M Gentile, X F Sun.   

Abstract

Previous studies have shown that nuclear p53 over-expression is an indicator of p53 mutations whereas cytoplasmic p53 accumulation is related to wild-type p53 in several kinds of tumors. Cytoplasmic p53 accumulation has been demonstrated to be an independent prognostic factor in colorectal adenocarcinomas. The purpose was to examine whether mutations occur in cases with p53 accumulated in the cytoplasm and whether there are any differences in the frequency and characteristics of p53 mutations in different staining patterns. In the present study, we identified p53 mutations using PCR single-strand conformation polymorphism (SSCP) and DNA sequencing in 75 primary colorectal adenocarcinomas with different staining patterns (negative, nucleus, cytoplasm, nucleus and cytoplasm). The results show that the frequency and nature of mutations in tumors with cytoplasmic p53 accumulation were similar to those with nuclear p53 expression. However, the tumors with accumulation in both the nucleus and cytoplasm demonstrated a higher mutation rate. We suppose that the role of cytoplasmic p53 accumulation in predicting prognosis in patients with colorectal cancer may be dependent on both mutational and non-mutational mechanisms. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11291068     DOI: 10.1002/ijc.1189

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Colorectal carcinoma prognosis can be predicted by alterations in gene p53 exons 5 and 8.

Authors:  M Vidaurreta; M L Maestro; M T Sanz-Casla; S Rafael; S Veganzones; V de la Orden; J Cerdán; M Arroyo; A Torres
Journal:  Int J Colorectal Dis       Date:  2008-03-06       Impact factor: 2.571

2.  The roles of p53 and XPO1 on colorectal cancer progression in Yemeni patients.

Authors:  Mohammed Aladhraei; Eman Al-Salami; Naravat Poungvarin; Prasit Suwannalert
Journal:  J Gastrointest Oncol       Date:  2019-06

3.  Nuclear and cytoplasmic p53 suppress cell invasion by inhibiting respiratory complex-I activity via Bcl-2 family proteins.

Authors:  Eun Mi Kim; Jong Kuk Park; Sang-Gu Hwang; Wun-Jae Kim; Zheng-Gang Liu; Sang Won Kang; Hong-Duck Um
Journal:  Oncotarget       Date:  2014-09-30

4.  Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma.

Authors:  Martin Köbel; Anna M Piskorz; Sandra Lee; Shuhong Lui; Cecile LePage; Francesco Marass; Nitzan Rosenfeld; Anne-Marie Mes Masson; James D Brenton
Journal:  J Pathol Clin Res       Date:  2016-07-13

5.  Differential expression patterns and clinical significance of estrogen receptor-α and β in papillary thyroid carcinoma.

Authors:  Yanhong Huang; Wenwu Dong; Jing Li; Hao Zhang; Zhongyan Shan; Weiping Teng
Journal:  BMC Cancer       Date:  2014-05-29       Impact factor: 4.430

6.  MicroRNA Expression Profile Reveals miR-17-92 and miR-143-145 Cluster in Synchronous Colorectal Cancer.

Authors:  Wen-Jian Meng; Lie Yang; Qin Ma; Hong Zhang; Gunnar Adell; Gunnar Arbman; Zi-Qiang Wang; Yuan Li; Zong-Guang Zhou; Xiao-Feng Sun
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.